Vitamin D Levels in Women With Polycystic Ovary Syndrome

• Status: Completed
• Trial end date: 2021-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%.

Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ghamra Military Hospital
• Collaborator: Al-Azhar University
• Treatments: Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion criteria:

• Hyperandrogenism

• Polycystic ovary syndrome

Exclusion Criteria:

• Thyroid disease

• Parathyroid disease

• Diabetes Mellitus

• Cushing syndrome

• Congenital adrenal hyperplasia

• Hyperprolactinemia

• Renal, liver or chronic disease